SCHEMBL13799307

SCHEMBL13799307

Oc1ccc(OCCOCCOCCOCCCCCCCCCCCS)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR5A1 Q13285 1/20 0.56
HDAC3 O15379 1/20 0.55
HDAC4 P56524 1/20 0.55
HDAC1 Q13547 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC2 Q92769 1/20 0.55
HDAC10 Q969S8 1/20 0.55
HDAC11 Q96DB2 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
HDAC9 Q9UKV0 1/20 0.55
HDAC5 Q9UQL6 1/20 0.55
APP P05067 1/20 0.51
LTA4H P09960 3/20 0.49
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
RARB P10826 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24799496 0.85 APP (0.61) NR5A1HDAC6APPLTA4HDRD2
SCHEMBL8674641 0.84 NR5A1 (0.58) NR5A1APPLTA4HMEN1USP2
SCHEMBL19284359 0.83 APP (0.67) NR5A1HDAC6APPLTA4HDRD2
SCHEMBL2471330 0.83 APP (0.67) NR5A1HDAC6APPLTA4HDRD2
SCHEMBL6860317 0.83 APP (0.67) NR5A1HDAC6APPLTA4HDRD2
SCHEMBL840786 0.83 NR5A1 (0.83) NR5A1APPLTA4HRARBMEN1
SCHEMBL840785 0.83 NR5A1 (0.83) NR5A1APPLTA4HRARBMEN1
SCHEMBL10357881 0.83 NR5A1 (0.83) NR5A1APPLTA4HRARBMEN1
SCHEMBL14566123 0.83 NR5A1 (0.83) NR5A1APPLTA4HRARBMEN1
SCHEMBL4167482 0.83 NR5A1 (0.56) NR5A1APPLTA4HDRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163380-A1 ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY STRATOS BIOSYSTEMS, LLC (US) 2009-06-25 US disclosed
US-20090163380-A1 ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY STRATOS BIOSYSTEMS, LLC (US) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163380-A1 ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY STUB1, SPR, DBI NR5A1 2146/4885HDAC3 4059/4885HDAC4 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.